Kraig Biocraft Laboratories Inc (KBLB)

[Lebbe1]

Kraig’s lead product is a genetically engineered spider silk known as Dragon Silk™. Its closely related sister product Monster Silk®. Both Dragon Silk™ and Monster Silk® are spun by lines of our transgenic silkworms. They are composed of a unique combination of spider silk protein and silkworm silk protein. These genetically engineered spider silks are significantly stronger and more flexible than commercial grade silk. We believe that this product will make significant inroads into both technical textile and mundane silk and apparel markets. The traditional silk market is estimated at approximately $3 to $5 billion (US) per year at the raw fiber level. Given its superior physical properties, Monster Silk™ particularly is well positioned to penetrate that market.
Dragon Silk™, represents a massive leap forward in the Company’s recombinant spider silk technology, combining both the elasticity and strength elements of native spider silk. We expect applications for form of spider silk, and its derivative products, to have uses in both the technical and protective textile markets.
Kraig is in the process of ramping up commercial production of its genetically engineered spider silks, including Monster Silk™ and Dragon Silk™.